AR025797A1 - QUINAZOLINONAS - Google Patents

QUINAZOLINONAS

Info

Publication number
AR025797A1
AR025797A1 ARP000105076A ARP000105076A AR025797A1 AR 025797 A1 AR025797 A1 AR 025797A1 AR P000105076 A ARP000105076 A AR P000105076A AR P000105076 A ARP000105076 A AR P000105076A AR 025797 A1 AR025797 A1 AR 025797A1
Authority
AR
Argentina
Prior art keywords
quinazolinonas
ibix
quinazolinones
clause
solvates
Prior art date
Application number
ARP000105076A
Other languages
Spanish (es)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR025797A1 publication Critical patent/AR025797A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Quinazolinonas de la formula (1) donde R, R1, R2, R3, R4, Y, Z, n y m tienen los valores que se indican en la cláusula 1, y sus sales o solvatos, que seutilizan como antagonistas de la glicoproteína IbIX.Quinazolinones of the formula (1) where R, R1, R2, R3, R4, Y, Z, n and m have the values indicated in clause 1, and their salts or solvates, which are used as IbIX glycoprotein antagonists.

ARP000105076A 1999-09-28 2000-09-27 QUINAZOLINONAS AR025797A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40795899A 1999-09-28 1999-09-28

Publications (1)

Publication Number Publication Date
AR025797A1 true AR025797A1 (en) 2002-12-11

Family

ID=23614261

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105076A AR025797A1 (en) 1999-09-28 2000-09-27 QUINAZOLINONAS

Country Status (8)

Country Link
EP (1) EP1216235A1 (en)
KR (1) KR20020047186A (en)
AR (1) AR025797A1 (en)
AU (1) AU7654800A (en)
BR (1) BR0014294A (en)
CA (1) CA2385921A1 (en)
NO (1) NO20021502D0 (en)
WO (1) WO2001023365A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7671200B2 (en) 1999-10-27 2010-03-02 Cytokinetics, Inc. Quinazolinone KSP inhibitors
WO2003106435A1 (en) * 2002-06-18 2003-12-24 Sankyo Company, Limited Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
US20040152696A1 (en) * 2002-08-01 2004-08-05 Euro-Celtique S.A. 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers
CA2502302A1 (en) * 2002-11-04 2004-05-21 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670416A1 (en) * 1966-12-30 1971-02-11 Chem Fab Von Heyden Gmbh Muenc Process for the preparation of amino-substituted quinazolinone derivatives
JPS6136273A (en) * 1984-07-26 1986-02-20 Mitsubishi Yuka Yakuhin Kk 2-phenylalkyl-4(3h)-quinazolinone derivative
CA2184891C (en) * 1994-03-08 2000-09-26 Yasuhisa Kuroki Phosphonic diester derivative
US5783577A (en) * 1995-09-15 1998-07-21 Trega Biosciences, Inc. Synthesis of quinazolinone libraries and derivatives thereof

Also Published As

Publication number Publication date
NO20021502L (en) 2002-03-26
BR0014294A (en) 2002-05-21
AU7654800A (en) 2001-04-30
EP1216235A1 (en) 2002-06-26
NO20021502D0 (en) 2002-03-26
WO2001023365A1 (en) 2001-04-05
KR20020047186A (en) 2002-06-21
CA2385921A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
UY34152A (en) ? SUBSTITUTED OXAZOLIDINONES AND ITS USE ?.
ES2122043T3 (en) NEW SUBSTITUTED DERIVATIVES OF PIRAZOLE, PROCEDURES FOR ITS PREPARATION AND USE AS HERBICIDES.
TR199801255T2 (en) Vitronectin receptor antagonists.
DK0960107T3 (en) 6-Thiosubstituted paclitaxels
PT1140944E (en) EPOTILONE DERIVATIVES AND THEIR USE AS ANTITUMATIC AGENTS
AR010062A1 (en) NEW BENZAMIDALDEHYDE AND ITS USE
ES2189235T3 (en) 6-REPLACED PHENYLPHENANTRIDINS.
TR199801253T2 (en) Vitronectin receptor antagonists.
ES2184077T3 (en) NEW FENANTRIDINS REPLACED IN POSITION 6.
TR200200795T2 (en) Piperazine derivatives as 5-HT1B antagonists
ATE416157T1 (en) INHIBITORS OF INTEGRIN ALPHA-V-BETA-6
AR025796A1 (en) QUINAZOLINONAS
ES2188759T3 (en) DERIVATIVES OF DOLASTATINE, ITS PREPARATION AND ITS USE.
ES2150039T3 (en) BENZONITRILS AS 5-HT AGONISTS AND ANTAGONISTS.
EE200000033A (en) Novel tetrazole derivatives
TR199701645A2 (en) Vitronectin receptor antagonists, their manufacture and use
PA8508301A1 (en) PROCOLAGEN PROTEIN C INHIBITORS
PT1086096E (en) BENZAMIDES WITH ETRA-HYDROFURANILOXI SUBSTITUTS AS PHOSPHODIESTERASE 4 INHIBITORS
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
ATE391488T1 (en) HAIR DYE COMPOSITIONS BASED ON DIAMINOPYRAZOLE COMPOUNDS
AR030537A1 (en) ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS
PA8466101A1 (en) THERAPEUTIC AGENTS
AR025797A1 (en) QUINAZOLINONAS
ATE287403T1 (en) 6-PHENYLBENZONAPHTHYIDINE
PA8465101A1 (en) TRIAZINE COMPOUNDS